Detalhe da pesquisa
1.
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 566(7745): E13, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733620
2.
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Nature
; 565(7738): 240-245, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568303
3.
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Acta Oncol
; 63: 385-391, 2024 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779910
4.
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Cancer
; 129(23): 3772-3782, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769113
5.
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
Oncologist
; 28(5): e242-e253, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961477
6.
Precision cancer medicine: Concepts, current practice, and future developments.
J Intern Med
; 294(4): 455-481, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37641393
7.
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
BMC Cancer
; 23(1): 182, 2023 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814246
8.
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Acta Oncol
; 62(12): 1653-1660, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874076
9.
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.
Oncology
; 100(2): 124-130, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844255
10.
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
BMC Cancer
; 22(1): 625, 2022 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672677
11.
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact.
Acta Oncol
; 61(12): 1499-1506, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529989
12.
Patients in phase 1 cancer trials: psychological distress and understanding of trial information.
Acta Oncol
; 61(3): 341-348, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709958
13.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466156
14.
Precision oncology: a clinical and patient perspective.
Future Oncol
; 17(30): 3995-4009, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278817
15.
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Mol Cell Proteomics
; 18(6): 1255-1268, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154438
16.
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Genes Chromosomes Cancer
; 59(3): 178-188, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31652375
17.
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial.
Lancet Oncol
; 21(9): 1234-1243, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818466
18.
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin.
Cancer
; 126(22): 4936-4947, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870522
19.
Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication.
Br J Cancer
; 123(6): 1033-1040, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632149
20.
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome.
Cytotherapy
; 22(4): 204-213, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201034